Epilepsy with Eyelid myoclonias - A diagnosis concealed in other genetic generalized epilepsies with photoparoxysmal response.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 26 08 2021
revised: 10 01 2022
accepted: 09 02 2022
pubmed: 19 2 2022
medline: 31 3 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

Epilepsy with eyelid myoclonias(EMA) is a genetic generalized epilepsy (GGE) characterized by eyelid myoclonia, eye-closure sensitivity and photosensitivity. Data on EMA patients who specifically present with photoparoxysmal response on EEG is lacking. EMA is an under-recognized syndrome which is frequently misclassified as another GGE. The main objective of our research is to describe the occurrence of EMA versus other GGEs among patients with photoparoxysmal response and evaluate their distinguishing features. We retrospectively identified all patients who had photoparoxysmal response on EEGs performed at Cleveland clinic between 01/01/2012 and 12/31/2019. Initial epilepsy diagnosis and clinical data were collected. EEGs were reviewed for eyelid myoclonia and eye-closure-sensitivity which were used as main diagnostic clues for EMA. If clinical criteria was met, diagnosis was revised as EMA. Of 249 patients with photoparoxysmal response, 70(28.1%) met EMA criteria. Sixty-two (88.6%) were females. Mean age of onset of epilepsy was 7 years (+7.9) and 120(48.2%) had other GGEs. Fifty-four (77.1%) patients with EMA were initially classified as another epilepsy. Initial diagnosis included CAE or JME in 40(57.1%) patients with EMA so we compared EMA with these syndromes. Female preponderance, drug refractoriness, older age of onset and generalized myoclonia were more common in EMA than CAE. Earlier age of onset, absence seizures, and lack of generalized myoclonic jerks were more common EMA than JME. Our study demonstrates that EMA is under-recognized among GGE patients with photoparoxysmal response. It highlights distinguishing clinical and electrographic features which separate EMA from other GGEs. It emphasizes the diverse treatments utilized and the need for therapeutic options for patients with refractory EMA.

Identifiants

pubmed: 35180638
pii: S0920-1211(22)00037-7
doi: 10.1016/j.eplepsyres.2022.106886
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106886

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Ifrah Zawar (I)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Neurology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: ifrah.zawar@gmail.com.

Martha Guadalupe Garcia Toribio (MGG)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: dra.garciatoribio@hotmail.com.

Xiaowei Xu (X)

Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzen, China. Electronic address: qyeileen@163.com.

Rawyah Saleh Alnakhli (RS)

Dr Sulaiman AlHabib Medical Group, Riyadh City, Riyadh Region, Saudi Arabia. Electronic address: ra_hajouj@hotmail.com.

Daniela Benech (D)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: danibenech@gmail.com.

Ahsan Moosa Naduvil Valappil (AMN)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: Naduvia@ccf.org.

Elaine Wyllie (E)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzen, China; Dr Sulaiman AlHabib Medical Group, Riyadh City, Riyadh Region, Saudi Arabia; Department of Neurology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: WYLLIEE@ccf.org.

Richard Burgess (R)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: burgesr@ccf.org.

Prakash Kotagal (P)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: KOTAGAP@ccf.org.

Deepak Lachhwani (D)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: LACHHWD@ccf.org.

Ajay Gupta (A)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: GUPTAA1@ccf.org.

Elia Pestana Knight (EP)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: pestane@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH